GEMINI-1 y GEMINI-2. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naïve adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Lancet 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0.




Pulse en la Imagen deseada para ampliar



0717192019
Diapositiva2
Diapositiva3
Diapositiva4
Diapositiva5
Diapositiva6
Diapositiva7
Diapositiva8
Diapositiva9
Diapositiva10